Filed: 8/14/2025ACC: 0000919574-25-004762
📋 What this filing means
CAXTON CORP filed this quarterly 13F‑HR report disclosing 11 equity positions with a total reported market value of $9.85M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
11
Positions
$9.85M
Total AUM (reported)
1.79M
Total Shares
Allocation by class
COM NEW$7.41M75.2%
GOLD SHS$1.51M15.3%
COM$629.7K6.4%
CL B NEW$307.0K3.1%
Portfolio Concentration
Top 3$8.97M91.0%
4–10$870.7K8.8%
11–25$12.1K0.1%
Top 3 weight
91.0%
Top 10 weight
99.9%
Voting Authority Distribution
Total shares with voting rights: 1.79M
Sole
Full voting authority
1.79M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole11
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings11
Rows:
REZOLUTE INC
SOLEShares1.60M
TypeSH
Market value$7.15M
72.60%
Sole
1.60M
Shared
0.00
None
0.00
SPDR GOLD TR
SOLEShares4.95K
TypeSH
Market value$1.51M
15.32%
Sole
4.95K
Shared
0.00
None
0.00
BERKSHIRE HATHAWAY INC DEL
SOLEShares632.00
TypeSH
Market value$307.0K
3.12%
Sole
632.00
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares13.10K
TypeSH
Market value$262.7K
2.67%
Sole
13.10K
Shared
0.00
None
0.00
MIND MEDICINE MINDMED INC
SOLEShares34.07K
TypeSH
Market value$221.1K
2.24%
Sole
34.07K
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
SOLEShares43.47K
TypeSH
Market value$113.0K
1.15%
Sole
43.47K
Shared
0.00
None
0.00
BICARA THERAPEUTICS INC
SOLEShares10.94K
TypeSH
Market value$101.6K
1.03%
Sole
10.94K
Shared
0.00
None
0.00
KYVERNA THERAPEUTICS INC
SOLEShares22.98K
TypeSH
Market value$70.6K
0.72%
Sole
22.98K
Shared
0.00
None
0.00
LEXEO THERAPEUTICS INC
SOLEShares17.33K
TypeSH
Market value$69.7K
0.71%
Sole
17.33K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares16.39K
TypeSH
Market value$32.0K
0.32%
Sole
16.39K
Shared
0.00
None
0.00
CONTEXT THERAPEUTICS INC
SOLEShares18.40K
TypeSH
Market value$12.1K
0.12%
Sole
18.40K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
REZOLUTE INCSOLE | COM NEW | 1.60M | SH | $7.15M 72.60% | 1.60M | 0.00 | 0.00 |
SPDR GOLD TRSOLE | GOLD SHS | 4.95K | SH | $1.51M 15.32% | 4.95K | 0.00 | 0.00 |
BERKSHIRE HATHAWAY INC DELSOLE | CL B NEW | 632.00 | SH | $307.0K 3.12% | 632.00 | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 13.10K | SH | $262.7K 2.67% | 13.10K | 0.00 | 0.00 |
MIND MEDICINE MINDMED INCSOLE | COM NEW | 34.07K | SH | $221.1K 2.24% | 34.07K | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCSOLE | COM | 43.47K | SH | $113.0K 1.15% | 43.47K | 0.00 | 0.00 |
BICARA THERAPEUTICS INCSOLE | COM | 10.94K | SH | $101.6K 1.03% | 10.94K | 0.00 | 0.00 |
KYVERNA THERAPEUTICS INCSOLE | COM | 22.98K | SH | $70.6K 0.72% | 22.98K | 0.00 | 0.00 |
LEXEO THERAPEUTICS INCSOLE | COM | 17.33K | SH | $69.7K 0.71% | 17.33K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 16.39K | SH | $32.0K 0.32% | 16.39K | 0.00 | 0.00 |
CONTEXT THERAPEUTICS INCSOLE | COM | 18.40K | SH | $12.1K 0.12% | 18.40K | 0.00 | 0.00 |